Compare EZGO & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZGO | BJDX |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 1.2M |
| IPO Year | 2021 | 2021 |
| Metric | EZGO | BJDX |
|---|---|---|
| Price | $1.83 | $0.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 67.2K | ★ 117.5K |
| Earning Date | 07-01-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $20,486,067.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $55.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.42 | N/A |
| 52 Week Low | $1.42 | $0.63 |
| 52 Week High | $17.24 | $10.20 |
| Indicator | EZGO | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 49.82 | 26.20 |
| Support Level | $1.93 | $0.63 |
| Resistance Level | $2.15 | $0.77 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 25.10 | 25.47 |
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.